40 research outputs found

    The incidence and significance of anti-natalizumab antibodies. Results from the AFFIRM and SENTINEL .

    No full text

    Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.

    No full text

    ‘PRIMO TRA COTANTO SENNO’: DANTE AND THE LATIN COMIC TRADITION

    No full text

    Alirocumab and cardiovascular outcomes after acute coronary syndrome

    No full text
    BACKGROUN

    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text
    corecore